Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay

por Yoshimi, Satoshi, Ochi, Hidenori, Murakami, Eisuke, Uchida, Takuro, Kan, Hiromi, Akamatsu, Sakura, Hayes, C. Nelson, Abe, Hiromi, Miki, Daiki, Hiraga, Nobuhiko, Imamura, Michio, Aikata, Hiroshi, Chayama, Kazuaki
Publicado 2015

Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus

por Miyaki, Eisuke, Hiraga, Nobuhiko, Imamura, Michio, Uchida, Takuro, Kan, Hiromi, Tsuge, Masataka, Abe-Chayama, Hiromi, Hayes, C. Nelson, Makokha, Grace Naswa, Serikawa, Masahiro, Aikata, Hiroshi, Ochi, Hidenori, Ishida, Yuji, Tateno, Chise, Ohdan, Hideki, Chayama, Kazuaki
Publicado 2017

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

por Nagaoki, Yuko, Imamura, Michio, Aikata, Hiroshi, Daijo, Kana, Teraoka, Yuji, Honda, Fumi, Nakamura, Yuki, Hatooka, Masahiro, Morio, Reona, Morio, Kei, Kan, Hiromi, Fujino, Hatsue, Kobayashi, Tomoki, Masaki, Keiichi, Ono, Atsushi, Nakahara, Takashi, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Kawakami, Yoshiiku, Hayes, C. Nelson, Miki, Daiki, Ochi, Hidenori, Chayama, Kazuaki
Publicado 2017